最新报道:According to a report from Bijie.com on October 7, MAIA Biotechnology, listed on NYSE American under the New York Stock Exchange, announced the official launch of its crypto treasury strategy. At the same time, its board of directors has approved the investment of 90% of the company's liquid assets in leading cryptocurrencies. The initial investment will purchase BTC, ETH and USDC. It is reported that the company will also establish a digital asset advisory committee to provide support for related purchase transactions.